Publikationen der ALS-Forschungsgruppe an der Charité
Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS
Münch C, Sedlmeier R, Meyer T, Homberg V, Sperfeld AD, Kurt A,
Chromosomal translocation t(18;21)(q23;q22.1) indicates novel susceptibility loci for frontotemporal dementia with ALS
Prudlo J, Alber B, Kalscheuer VM, Roemer K, Martin T, Dullinger J,
High rate of constitutional chromosomal rearrangements in apparently sporadic ALS
Meyer T, Alber B, Roemer K, Martin T, Kalscheuer VM, Göttert E,
The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals
Meyer T, Fromm A, Münch C, Schwalenstöcker B, Fray AE, Ince PG,
The EAAT2 (GLT-1) gene in motor neuron disease: absence of mutations in amyotrophic lateral sclerosis and a point mutation in patients with hereditary spastic paraplegia
Meyer T, Münch C, Völkel H, Booms P, Ludolph AC. The EAAT2
Studies of the coding region of the neuronal glutamate transporter gene in amyotrophic lateral sclerosis
Meyer T, Lenk U, Küther G, Weindl A, Speer A, Ludolph AC.
Publikationen mit Beteiligung der ALS-Forschungsgruppe an der Charité
A mapping review of international guidance on the management and care of amyotrophic lateral sclerosis (ALS)
Janssens AI, Ruytings M, Al-Chalabi A,
Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis
Vercruysse P, Sinniger J, El Oussini
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
Freischmidt A, Wieland T, Richter B,
Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study
Dorst J, Dupuis L, Petri S,
A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity
Joyce PI, Mcgoldrick P, Saccon RA,
Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression
Küffner R, Zach N, Norel R,
Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study
van Doormaal PT, Ticozzi N, Gellera
A phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis
Lenglet T, Lacomblez L, Abitbol JL,
Live and let die: existential decision processes in a fatal disease
Lulé D, Nonnenmacher S, Sorg S,
In vivo waveguide elastography: effects of neurodegeneration in patients with amyotrophic lateral sclerosis
Romano A, Guo J, Prokscha T, Meyer
